Mizuho Lowers UnitedHealth Group (NYSE:UNH) Price Target to $350.00

UnitedHealth Group (NYSE:UNH) had its price objective decreased by equities research analysts at Mizuho from $430.00 to $350.00 in a research note issued on Thursday,Benzinga reports. The brokerage currently has an “outperform” rating on the healthcare conglomerate’s stock. Mizuho’s price target would suggest a potential upside of 26.95% from the stock’s previous close.

UNH has been the subject of a number of other reports. Sanford C. Bernstein reiterated an “outperform” rating on shares of UnitedHealth Group in a research report on Wednesday, January 28th. Truist Financial reduced their price objective on shares of UnitedHealth Group from $410.00 to $370.00 and set a “buy” rating on the stock in a research note on Monday. Barclays reduced their price target on shares of UnitedHealth Group from $391.00 to $327.00 and set an “overweight” rating on the stock in a research report on Friday, January 30th. UBS Group reduced their target price on UnitedHealth Group from $430.00 to $410.00 and set a “buy” rating on the stock in a report on Wednesday, January 28th. Finally, Leerink Partners reduced their price objective on UnitedHealth Group from $410.00 to $345.00 and set an “outperform” rating on the stock in a research note on Wednesday, January 28th. One analyst has rated the stock with a Strong Buy rating, seventeen have assigned a Buy rating, nine have given a Hold rating and two have given a Sell rating to the stock. According to MarketBeat, the company currently has an average rating of “Moderate Buy” and an average target price of $372.13.

UnitedHealth Group Trading Down 3.0%

UNH stock opened at $275.70 on Thursday. UnitedHealth Group has a 52 week low of $234.60 and a 52 week high of $606.36. The company has a debt-to-equity ratio of 0.72, a quick ratio of 0.82 and a current ratio of 0.79. The company’s 50-day simple moving average is $328.16 and its 200 day simple moving average is $323.39. The company has a market capitalization of $249.74 billion, a PE ratio of 20.90, a price-to-earnings-growth ratio of 1.31 and a beta of 0.41.

UnitedHealth Group (NYSE:UNH) last announced its earnings results on Tuesday, January 27th. The healthcare conglomerate reported $2.11 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $2.09 by $0.02. The firm had revenue of $113.22 billion for the quarter, compared to analyst estimates of $113.38 billion. UnitedHealth Group had a net margin of 2.69% and a return on equity of 14.79%. The business’s revenue was up 12.3% compared to the same quarter last year. During the same quarter in the prior year, the business posted $6.81 EPS. UnitedHealth Group has set its FY 2026 guidance at 17.750- EPS. As a group, sell-side analysts anticipate that UnitedHealth Group will post 29.54 earnings per share for the current year.

Institutional Trading of UnitedHealth Group

Several institutional investors have recently modified their holdings of the business. LFA Lugano Financial Advisors SA bought a new stake in shares of UnitedHealth Group in the 2nd quarter valued at about $25,000. Beacon Financial Strategies CORP bought a new stake in UnitedHealth Group in the fourth quarter valued at approximately $26,000. Anfield Capital Management LLC lifted its position in shares of UnitedHealth Group by 220.0% in the 4th quarter. Anfield Capital Management LLC now owns 80 shares of the healthcare conglomerate’s stock worth $26,000 after purchasing an additional 55 shares during the period. Joseph Group Capital Management acquired a new stake in shares of UnitedHealth Group during the fourth quarter worth $27,000. Finally, Sagard Holdings Management Inc. acquired a new position in UnitedHealth Group in the second quarter valued at $29,000. Institutional investors own 87.86% of the company’s stock.

Trending Headlines about UnitedHealth Group

Here are the key news stories impacting UnitedHealth Group this week:

• Positive Sentiment: Wall‑street consensus remains constructive: analysts still rate UNH a “Moderate Buy,” supporting demand under the selloff. UnitedHealth Group Incorporated (NYSE:UNH) Given Consensus Recommendation of “Moderate Buy” by Analysts
• Positive Sentiment: Bullish investors argue the Q4 weakness and Medicare payment noise create a buy‑the‑dip opportunity — management strength, Optum cost initiatives (AI) and insider/long‑term buyer activity are cited as catalysts for recovery. UnitedHealth: Buy The Dip As Multiple Factors Could Drive Strong Long-Term Returns
• Positive Sentiment: Analyst coverage remains tilted to buy with a median 6‑month target well above current levels (median ≈ $390), providing potential support if earnings and policy clarity return. UnitedHealth Group Stock (UNH) Opinions on Earnings and CMS Medicare Rate Notice
• Neutral Sentiment: Corporate leadership news: UnitedHealth marketing/customer executive Terry Clark was named CEO at the PGA of America — a non‑operational item with limited direct impact on UNH fundamentals. Health care executive Terry Clark is appointed CEO at the PGA of America
• Negative Sentiment: Regulatory risk intensified after reports that DOJ is probing UnitedHealth, adding execution and legal overhang that can pressure valuation until resolved. UnitedHealth Group Faces DOJ Probe And Regulatory Questions For Future Returns
• Negative Sentiment: Earnings and margin worries: Q4 showed a revenue miss and a higher medical care ratio, prompting investor questions about margin trajectory and membership shedding choices that could weigh near‑term results. UnitedHealth Group FQ4 Earnings: Why Top Analysts Ask About Its Margin
• Negative Sentiment: Policy shock from the CMS advance notice (near‑flat Medicare rate growth) and ensuing headlines triggered heavy selling earlier — a structural reimbursement risk that directly pressures Medicare Advantage margins. UnitedHealth Group Stock (UNH) Opinions on Earnings and CMS Medicare Rate Notice
• Negative Sentiment: Recent analyst caution and negative headlines (“more bad news”) have amplified volatility and downside pressure while the market re‑prices regulatory, reimbursement and utilization risks. UnitedHealth Group Just Received More Bad News. Here’s What Investors Should Know.

UnitedHealth Group Company Profile

UnitedHealth Group Inc is a diversified health care company headquartered in Minnetonka, Minnesota, that operates two primary business platforms: UnitedHealthcare and Optum. Founded in 1977, the company provides a broad range of health benefits and health care services to individuals, employers, governmental entities and other organizations. Its operations span commercial employer-sponsored plans, individual and Medicare and Medicaid programs, and services for customers and health systems in the United States and selected international markets.

UnitedHealthcare is the company’s benefits business, administering health plans and networks, managing provider relationships, and offering coverage products for employers, individuals, and government-sponsored programs.